共 50 条
- [1] Real-World Outcomes with CPX-351 Induction in Adults with Newly Diagnosed Acute Myeloid Leukemia[J]. BLOOD, 2023, 142Bennett, Joseph G.Gilmore, DrakeMale, Heather J.Byrd, Kenneth P.Lin, Tara L.Gonzalez-Lugo, Jesus D.
- [2] CPX-351 Treatment for Acute Myeloid Leukaemia in England: Real-world Outcomes in Adults Aged <60 Years[J]. BRITISH JOURNAL OF HAEMATOLOGY, 2022, 197 : 59 - 60Legg, AlexReich, AdamWilkes, EmilyMedalla, Greg
- [3] Real-world effectiveness of CPX-351 vs venetoclax and azacitidine in acute myeloid leukemia[J]. BLOOD ADVANCES, 2022, 6 (13) : 3997 - 4005Matthews, Andrew H.Perl, Alexander E.Luger, Selina M.Loren, Alison W.Gill, Saar I.Porter, David L.Babushok, Daria V.Maillard, Ivan P.Carroll, Martin P.Frey, Noelle V.Hexner, Elizabeth O.Martin, Mary EllenMcCurdy, Shannon R.Stadtmauer, Edward A.Paralkar, Vikram R.Bruno, Ximena JordanHwang, Wei -TingMargolis, DavidPratz, Keith W.
- [4] Real-world experience with CPX-351 in high-risk acute myeloid leukemia[J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2023, 185Lemoli, Roberto M.Montesinos, PauJain, Akriti
- [5] Real-world experience of CPX-351 as first-line treatment for patients with acute myeloid leukemia[J]. Blood Cancer Journal, 11Christina RautenbergFriedrich StölzelChristoph RölligMatthias StelljesVerena GaidzikMichael LausekerOliver KriegeMareike VerbeekJulia Marie UnglaubFelicitas TholStefan W. KrauseMathias HänelCharlotte NeuerburgVladan VucinicChristian-Friedrich JehnJulia SevermannMaxi WassLars FranseckyJens ChemnitzUdo HoltickKerstin Schäfer-EckartJosephine SchröderSabrina KrausWilliam KrügerUlrich KaiserSebastian SchollKathrin KochLea HenningGuido KobbeRainer HaasNael AlakelMaximilian-Alexander RöhnertKatja SockelMaher HanounUwe PlatzbeckerTobias A. W. HolderriedAnke MorgnerMichael HeuserTim SauerKatharina S. GötzeEva Wagner-DrouetKonstanze DöhnerHartmut DöhnerChristoph SchliemannJohannes ScheteligMartin BornhäuserUlrich GermingThomas SchroederJan Moritz Middeke
- [6] Real-world experience of CPX-351 as first-line treatment for patients with acute myeloid leukemia[J]. BLOOD CANCER JOURNAL, 2021, 11 (10)Rautenberg, ChristinaStoelzel, FriedrichRoellig, ChristophStelljes, MatthiasGaidzik, VerenaLauseker, MichaelKriege, OliverVerbeek, MareikeUnglaub, Julia MarieThol, FelicitasKrause, Stefan W.Haenel, MathiasNeuerburg, CharlotteVucinic, VladanJehn, Christian-FriedrichSevermann, JuliaWass, MaxiFransecky, LarsChemnitz, JensHoltick, UdoSchaefer-Eckart, KerstinSchroeder, JosephineKraus, SabrinaKrueger, WilliamKaiser, UlrichScholl, SebastianKoch, KathrinHenning, LeaKobbe, GuidoHaas, RainerAlakel, NaelRoehnert, Maximilian-AlexanderSockel, KatjaHanoun, MaherPlatzbecker, UweHolderried, Tobias A. W.Morgner, AnkeHeuser, MichaelSauer, TimGoetze, Katharina S.Wagner-Drouet, EvaDoehner, KonstanzeDoehner, HartmutSchliemann, ChristophSchetelig, JohannesBornhaeuser, MartinGerming, UlrichSchroeder, ThomasMiddeke, Jan Moritz
- [7] Real-World Experience of CPX-351 As First-Line Treatment in 188 Patients with Acute Myeloid Leukemia[J]. BLOOD, 2021, 138Rautenberg, ChristinaStoelzel, FriedrichRoellig, ChristophStelljes, MatthiasGaidzik, VerenaLauseker, MichaelKriege, OliverVerbee, MareikeUnglaub, Julia MarieThol, FelicitasKrause, Stefan W.Haenel, MathiasNeuerburg, CharlotteVucinic, VladanJehn, Christian-FriedrichSevermann, JuliaWass, MaxiFransecky, LarsChemnitz, JensHoltick, UdoSchaefer-Eckart, KerstinSchroeder, JosephineKraus, SabrinaKrueger, WilliamKaiser, UlrichScholl, SebastianKoch, KathrinHenning, LeaKobbe, GuidoHaas, RainerAlakel, NaelRoehnert, Maximilian-AlexanderSockel, KatjaHanoun, MaherPlatzbecker, UweHolderried, Tobias A. W.Morgner, AnkeHeuser, MichaelSauer, TimGoetze, Katharina S.Wagner-Drouet, EvaDoehne, KonstanzeDoehner, HartmutSchliemann, ChristophSchetelig, JohannesBornhaeuser, MartinGerming, UlrichSchroeder, ThomasMiddeke, Jan Moritz
- [8] Real-World Experience With CPX-351 Treatment for Acute Myeloid Leukemia in England: An Analysis From the National Cancer Registration and Analysis Service[J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 (10): : E323 - E330Legg, AlexLambova, AlexandrinaBroe, AnneLevy, JuliaMedalla, Greg
- [9] Real World Outcomes of CPX-351 Compared to Traditional Chemotherapy with Cytarabine Consolidation for Treatment of Secondary Acute Myeloid Leukemia[J]. BLOOD, 2023, 142Granger, KatelynnGaffney, Kelly J.Smith, DeidraWeeda, ErinBaratam, PraneethGreen, Kimberly MichelleColtoff, AlexanderDavis, James A.
- [10] Phase II Study of CPX-351 Plus Venetoclax in Patients with Acute Myeloid Leukemia (AML)[J]. BLOOD, 2020, 136Kadia, Tapan M.Borthakur, GautamTakahashi, KoichiDiNardo, Courtney D.Daver, NavalPemmaraju, NaveenJabbour, EliasJain, NitinShort, Nicholas J.Qiao, WeiAdewale, LadeRausch, Caitlin R.Pierce, Sherry A.Alvarado, YesidAlousi, Amin M.Popat, Uday R.Khouri, Issa F.Garcia-Manero, GuillermoKonopleva, MarinaCortes, Jorge E.Ravandi, FarhadKantarjian, Hagop M.